amgen
Scope
Date
~
-
Bio & PharmaSamsung, Celltrion lead biosimilar market in Europe, US
Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz in the antibody biosim...
Mar 10, 2025 (Gmt+09:00)
-
Bio & PharmaCelltrion revises up earnings goals to overtake Amgen
Celltrion Inc., South Korea's leading biosimilar maker, on Wednesday expressed its ambition to join the global top 10 biotech and pharmaceutical com...
Jan 11, 2024 (Gmt+09:00)
-
Bio & PharmaLegoChem Bio, Amgen sign ADC platform deal for up to $1.2 bn
South Korean pharmaceutical firm LegoChem Biosciences Inc. said on Dec. 23 it has transferred the antibody-drug conjugates (ADC) technology platform...
Dec 23, 2022 (Gmt+09:00)
-
Bio & PharmaSamsung Bioepis’ SB12 shows same clinical effects as Alexion’s Soliris
Samsung Bioepis Co., a biopharmaceutical unit of Samsung Group, said its SB12, a proposed biosimilar to Alexion Pharmaceuticals Inc.’s rare bl...
Jun 14, 2022 (Gmt+09:00)
language
Latest News
- 1 NCSOFT invests in US game startup emptyvessel
- 2 Maybe Happy Ending: How a Seoul-made robot love story rewrote Broadway playbook
- 3 NPS yet to schedule external manager selection; PE firms’ fundraising woes deepen
- 4 Woori Financial wins approval for Tongyang, ABL Life acquisition
- 5 BMW surpasses Mercedes in Korean sales amid imported vehicle market shake-up
